Staphyloxanthin inhibitory potential of trans-anethole: A preliminary study.

Carotenoids Gene expression HPLC-MS Staphylococcus aureus Staphyloxanthin Trans-anethole

Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 05 11 2022
revised: 13 12 2022
accepted: 21 12 2022
pubmed: 26 12 2022
medline: 19 1 2023
entrez: 25 12 2022
Statut: ppublish

Résumé

The reduction of staphyloxanthin (STX) production in Staphylococcus aureus under trans-anethole (TA) influence was proven in former studies. However, no tests concerning the impact of TA on a biosynthetic pathway of this carotenoid pigment have been published so far. Thus, for the first time, the present preliminary study evaluated the influence of TA on the expression level of genes (crtOPQMN operon and aldH) encoding STX pathway enzymes. Additional attention was paid to the identification of STX and its intermediates. Gene expression and identification of extracted compounds were conducted using quantitative real-time PCR and HPLC-MS techniques, respectively. The analyzes showed no difference in crtM, crtN, crtO, crtP, crtQ, and aldH gene expression between bacterial samples isolated from the non-stimulated (control) medium and the stimulated one with TA. Compared to the control group that showed the presence of all metabolic intermediates and STX, the TA-treated bacteria were characterized by a lack or a significant reduction of the majority of compounds, except 4,4'-diaponeurosporenoate, the content of which was elevated in the TA-treated sample. Moreover, in silico molecular docking analysis revealed that TA is capable to create relatively strong interactions with both 4,4'-diapophytoene synthase and 4,4'-diapophytoene desaturase. The preliminary findings indicate that the previously observed TA effect reducing the number of S. aureus colonies pigmentation is probably not associated with the expression levels of genes encoding STX pathway enzymes. It has been proven that adding TA to the medium can interfere with the formation of STX at different levels of its biosynthetic pathway.

Identifiants

pubmed: 36566523
pii: S0753-3322(22)01542-6
doi: 10.1016/j.biopha.2022.114153
pii:
doi:

Substances chimiques

staphyloxanthin 71869-01-7
anethole Q3JEK5DO4K
Xanthophylls 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114153

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement The authors declare no conflict of interest in the publication of research article entitled: Staphyloxanthin inhibitory potential of trans-anethole: a preliminary study.

Auteurs

Paweł Kwiatkowski (P)

Department of Diagnostic Immunology, Pomeranian Medical University in Szczecin, Poland. Electronic address: pawel.kwiatkowski@pum.edu.pl.

Mateusz Kurzawski (M)

Department of Experimental and Clinical Pharmacology, Pomeranian Medical University in Szczecin, Poland.

Wirginia Kukula-Koch (W)

Department of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, Poland.

Agata Pruss (A)

Department of Laboratory Medicine, Pomeranian Medical University in Szczecin, Poland.

Monika Sienkiewicz (M)

Department of Pharmaceutical Microbiology and Microbiological Diagnostic, Medical University of Lodz, Poland.

Wojciech Płaziński (W)

Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Krakow, Poland; Department of Biopharmacy, Medical University of Lublin, Poland.

Barbara Dołęgowska (B)

Department of Laboratory Medicine, Pomeranian Medical University in Szczecin, Poland.

Iwona Wojciechowska-Koszko (I)

Department of Diagnostic Immunology, Pomeranian Medical University in Szczecin, Poland.

Articles similaires

Animals Hemiptera Insect Proteins Phylogeny Insecticides
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics
Animals Osteoarthritis Rats NF-kappa B Male

Classifications MeSH